Napyo, Agnes
Nakiyemba, Alice
Muduwa, Martha
Ssenkusu, John M.
Okello, Francis
Hagmann, Cornelia
Namuyonga, Judith
Hewitt-Smith, Adam
Loe, Kate
Grace, Abongo
Denis, Amorut
Wandabwa, Julius
Olupot-Olupot, Peter
Burgoine, Kathy
Funding for this research was provided by:
Joint Global Health Trials Development Grant (MR/V004468/1, MR/V004468/1, MR/V004468/1, MR/V004468/1, MR/V004468/1, MR/V004468/1, MR/V004468/1, MR/V004468/1, MR/V004468/1, MR/V004468/1)
Article History
Received: 7 May 2025
Accepted: 12 August 2025
First Online: 24 September 2025
Declarations
:
: This study was conducted to the highest ethical and governance standards in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice. The study was given ethical approval by Mbale Regional Referral Hospital research ethics committee (MRRH-REC, 123) and Uganda National Council of Science and Technology (UNCST, HS2605ES). Administrative approval was provided by Mbale Regional Referral Hospital. In alignment with the funder’s requirements, ethical opinion was sought from a UK Research and Ethics Committee, resulting in a favourable ethical opinion from Liverpool School of Tropical Medicine Research Ethics Committee. Full written informed consent was provided by the mother and/or father for each infant enrolled in the DR-CPAP trial. For the qualitative component reported in this manuscript, separate written informed consent was sought from the mothers, fathers, other caregivers and healthcare workers. All participants in the qualitative study were over 16 years of age.
: Not applicable.
: The authors declare no competing interests.